COVID-19 vaccination was significantly associated with reduced risk of developing persistent long COVID, particularly when at least 2 doses were administered.

A highly transmissible new COVID-19 variant called NB.1.8.1, aka "Nimbus," is spreading in the United States, CDC data show.

The vaccine eligibility change is a threat to the health of Americans, some experts say, adding that the FDA is not being forthcoming about its research.

Several new studies have identified biomarkers of long COVID, which can tell us more about what causes the disease. These ...

Last month, the World Health Organization labeled the COVID variant NB.1.8.1 a “variant under monitoring” because it has been ...

A new study of over 13 million people in England has found no evidence to suggest mild COVID-19 infection may cause long-term ...

Local doctors say they will continue to advise patients “based on science” and caution people about the ongoing public health ...

The Food and Drug Administration says it has decided to continue approving COVID-19 vaccine updates for seniors and others at higher risk of severe disease, but will require vaccine makers to ...

Some trials are focusing on drugs that target the immune system, which is affected by different pathways to long COVID ...

By now, we're likely all familiar with the more general Covid symptoms of a temperature, loss of taste or smell, and a cough. But when it comes the NB.1.8.1., Dr Wylie says early reports indicate ...

And, starting with new boosters coming this fall, the Food and Drug Administration will now only approve the shots for people who are at high risk for serious complications from COVID because they are ...